Search Results for: LRP1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
CCN2 cellular communication network factor 2
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • RUNX3 regulates YAP1-mediated transcription
CD82 CD82 molecule
CTSG cathepsin G
  • Degradation of the extracellular matrix
  • Activation of Matrix Metalloproteinases
  • Metabolism of Angiotensinogen to Angiotensins
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Interleukin-1 processing
  • Neutrophil degranulation
  • Antimicrobial peptides
  • Suppression of apoptosis
  • Purinergic signaling in leishmaniasis infection
  • Bis-Napthyl Beta-Ketophosphonic Acid
  • 2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid
DAB1 DAB adaptor protein 1
  • Reelin signalling pathway
DAB2 DAB adaptor protein 2
  • Gap junction degradation
  • Formation of annular gap junctions
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
DLG4 discs large MAGUK scaffold protein 4
  • Signaling by ERBB4
  • Trafficking of AMPA receptors
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Unblocking of NMDA receptors, glutamate binding and activation
  • Ras activation upon Ca2+ influx through NMDA receptor
  • NrCAM interactions
  • Activation of Ca-permeable Kainate Receptor
  • RHO GTPases activate CIT
  • RAF/MAP kinase cascade
  • LGI-ADAM interactions
  • Neurexins and neuroligins
  • Neurexins and neuroligins
  • Synaptic adhesion-like molecules
  • Assembly and cell surface presentation of NMDA receptors
  • Negative regulation of NMDA receptor-mediated neuronal transmission
  • Long-term potentiation
  • Guanidine
  • Guanosine-5'-Monophosphate
EGFR epidermal growth factor receptor
  • Signaling by ERBB2
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Signaling by ERBB4
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • PLCG1 events in ERBB2 signaling
  • PIP3 activates AKT signaling
  • Signaling by EGFR
  • GRB2 events in EGFR signaling
  • GAB1 signalosome
  • SHC1 events in EGFR signaling
  • EGFR downregulation
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • EGFR interacts with phospholipase C-gamma
  • EGFR Transactivation by Gastrin
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Signal transduction by L1
  • Constitutive Signaling by EGFRvIII
  • Inhibition of Signaling by Overexpressed EGFR
  • RAF/MAP kinase cascade
  • ERBB2 Regulates Cell Motility
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • ERBB2 Activates PTK6 Signaling
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • PTK6 promotes HIF1A stabilization
  • Downregulation of ERBB2 signaling
  • TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
  • Extra-nuclear estrogen signaling
  • NOTCH3 Activation and Transmission of Signal to the Nucleus
  • HCMV Early Events
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
  • Cetuximab
  • Lidocaine
  • Gefitinib
  • Erlotinib
  • Lapatinib
  • Panitumumab
  • Alvocidib
  • IGN311
  • Matuzumab
  • Vandetanib
  • Rindopepimut
  • Canertinib
  • Pelitinib
  • Varlitinib
  • AV-412
  • S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE
  • PD-168393
  • Afatinib
  • Osimertinib
  • Necitumumab
  • Foreskin keratinocyte (neonatal)
  • Depatuxizumab mafodotin
  • Icotinib
  • Neratinib
  • Dacomitinib
  • Fostamatinib
  • Zalutumumab
  • Brigatinib
  • Olmutinib
  • Zanubrutinib
  • Abivertinib
  • Choriocarcinoma
  • Gastric cancer
  • Bladder cancer
  • Oral cancer
  • Glioma
  • Laryngeal cancer
  • Cervical cancer
  • Esophageal cancer
ELANE elastase, neutrophil expressed
  • Collagen degradation
  • Degradation of the extracellular matrix
  • Degradation of the extracellular matrix
  • Activation of Matrix Metalloproteinases
  • Neutrophil degranulation
  • Antimicrobial peptides
  • Regulation of Complement cascade
  • Alpha-1-proteinase inhibitor
  • Filgrastim
  • Mdl 101,146
  • Freselestat
  • Elafin
  • Neutropenic disorders, including the following three diseases: Kostmann syndrome; Cyclic neutropenia; X-linked neutropenia/myelodysplasia
F8 coagulation factor VIII
  • Platelet degranulation
  • Intrinsic Pathway of Fibrin Clot Formation
  • Common Pathway of Fibrin Clot Formation
  • Gamma carboxylation, hypusine formation and arylsulfatase activation
  • COPII-mediated vesicle transport
  • Cargo concentration in the ER
  • Defective factor IX causes thrombophilia
  • Defective F8 accelerates dissociation of the A2 domain
  • Defective F8 cleavage by thrombin
  • Defective F8 binding to von Willebrand factor
  • Defective F8 binding to the cell membrane
  • Defective cofactor function of FVIIIa variant
  • Defective F8 secretion
  • Defective F9 variant does not activate FX
  • Defective F8 sulfation at Y1699
  • Drotrecogin alfa
  • Coagulation Factor IX (Recombinant)
  • TB-402
  • Thrombin
  • Protein C
  • Human thrombin
  • Thrombin alfa
  • Vonicog Alfa
  • Von Willebrand Factor Human
  • Anti-inhibitor coagulant complex
  • Coagulation Factor IX Human
  • Nonacog beta pegol
  • Damoctocog alfa pegol
  • Hemophilia; Hemophilia A (HEMA); Hemophilia B (HEMB); von Willebrand disease (VWD)
F9 coagulation factor IX
  • Extrinsic Pathway of Fibrin Clot Formation
  • Intrinsic Pathway of Fibrin Clot Formation
  • Gamma-carboxylation of protein precursors
  • Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
  • Removal of aminoterminal propeptides from gamma-carboxylated proteins
  • Defective factor IX causes thrombophilia
  • Defective cofactor function of FVIIIa variant
  • Defective F9 variant does not activate FX
  • Defective F9 secretion
  • Defective F9 activation
  • Defective gamma-carboxylation of F9
  • Antihemophilic factor, human recombinant
  • Menadione
  • TTP889
  • Turoctocog alfa
  • Kappadione
  • Coagulation factor VII human
  • Antihemophilic factor human
  • Emicizumab
  • Lonoctocog alfa
  • Moroctocog alfa
  • Turoctocog alfa pegol
  • Hemophilia; Hemophilia A (HEMA); Hemophilia B (HEMB); von Willebrand disease (VWD)
FURIN furin, paired basic amino acid cleaving enzyme
  • Signaling by NODAL
  • Collagen degradation
  • Collagen degradation
  • Elastic fibre formation
  • Activation of Matrix Metalloproteinases
  • Removal of aminoterminal propeptides from gamma-carboxylated proteins
  • NGF processing
  • Synthesis and processing of ENV and VPU
  • Signaling by PDGF
  • Pre-NOTCH Processing in Golgi
  • TGF-beta receptor signaling activates SMADs
  • Uptake and function of anthrax toxins
  • Formation of the cornified envelope
  • Assembly of active LPL and LIPC lipase complexes
  • CD163 mediating an anti-inflammatory response
  • Potential therapeutics for SARS
  • Attachment and Entry
  • Amyloid fiber formation
  • Capric acid
GIPC1 GIPC PDZ domain containing family member 1
GTPBP1 GTP binding protein 1
GULP1 GULP PTB domain containing engulfment adaptor 1
HNRNPDL heterogeneous nuclear ribonucleoprotein D like
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
HSP90B1 heat shock protein 90 beta family member 1
  • Trafficking and processing of endosomal TLR
  • Scavenging by Class A Receptors
  • Scavenging by Class A Receptors
  • ATF6 (ATF6-alpha) activates chaperone genes
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Interleukin-4 and Interleukin-13 signaling
  • Post-translational protein phosphorylation
  • Rifabutin
  • 2-Chlorodideoxyadenosine
  • Geldanamycin
  • Diglyme
  • N-Ethyl-5'-Carboxamido Adenosine
  • Radicicol
  • METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE
  • 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE
  • Copper
ITGB1BP1 integrin subunit beta 1 binding protein 1
KAT5 lysine acetyltransferase 5
  • Formation of the beta-catenin:TCF transactivating complex
  • Formation of the beta-catenin:TCF transactivating complex
  • DNA Damage/Telomere Stress Induced Senescence
  • HATs acetylate histones
  • HDR through Single Strand Annealing (SSA)
  • HDR through Homologous Recombination (HRR)
  • Sensing of DNA Double Strand Breaks
  • Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Resolution of D-loop Structures through Holliday Junction Intermediates
  • Nonhomologous End-Joining (NHEJ)
  • Homologous DNA Pairing and Strand Exchange
  • Processing of DNA double-strand break ends
  • Presynaptic phase of homologous DNA pairing and strand exchange
  • Regulation of TP53 Activity through Phosphorylation
  • G2/M DNA damage checkpoint
  • Estrogen-dependent gene expression
  • Coenzyme A
  • S-Acetyl-Cysteine
LIPC lipase C, hepatic type
  • Assembly of active LPL and LIPC lipase complexes
  • Chylomicron clearance
LPL lipoprotein lipase
  • Transcriptional regulation of white adipocyte differentiation
  • Assembly of active LPL and LIPC lipase complexes
  • Chylomicron remodeling
  • Retinoid metabolism and transport
  • Tyloxapol
  • Omega-3-carboxylic acids
  • Glycyrrhizic acid
  • Hyperlipoproteinemia, type I

Page 2 out of 4 pages